Hiscox Ltd Stock London S.E.
Equities
HSX
BMG4593F1124
Property & Casualty Insurance
End-of-day quote
Other stock markets
|
||
- GBP | - |
May. 08 | UBS raises Centrica to 'buy' from 'neutral | AN |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.89B 4.94B | Sales 2025 * | 4.27B 5.42B | Capitalization | 3.99B 5.07B |
---|---|---|---|---|---|
Net income 2024 * | 469M 596M | Net income 2025 * | 504M 640M | EV / Sales 2024 * | 1.03 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.93 x |
P/E ratio 2024 * |
8.55
x | P/E ratio 2025 * |
7.85
x | Employees | - |
Yield 2024 * |
2.78% | Yield 2025 * |
3.08% | Free-Float | 97.42% |
Latest transcript on Hiscox Ltd
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 16-04-21 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 22-05-11 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 10-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 17-11-15 | |
Anne MacDonald
BRD | Director/Board Member | 68 | 15-05-19 |
Colin Keogh
BRD | Director/Board Member | 69 | 15-11-18 |
1st Jan change | Capi. | |
---|---|---|
+44.04% | 62.4B | |
+16.30% | 52.29B | |
+13.18% | 49.37B | |
+19.92% | 44.3B | |
+12.64% | 30.08B | |
+70.34% | 28.2B | |
+26.88% | 25.7B | |
+2.07% | 21.96B | |
+15.46% | 21.32B |
- Stock Market
- Equities
- HSX Stock
- HSX Stock